EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma

David Stahl, Philipp Gödel, Hyatt Balke-Want, Rahil Gholamipoorfard, Paul Segbers, Luis Tetenborg, Mirjam Koker, Janina Dörr, Lisa Gregor, Daniel Bachurski, France Rose, Adrian G Simon und 44 weitere

Cancer Cell · 2025-08 · 43 (8) · 1476-1494.e10

DOI: 10.1016/j.ccell.2025.05.013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Cell, 2025-08. Verfasst von David Stahl und 55 weiteren Autor:innen. Beteiligte Einrichtung: Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and Uni…. Hauptthemen laut MEDLINE: Immunotherapy, Adoptive, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, Lymphoma, B-Cell, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Horizon 2020, Hector Stiftung.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the improvement, approximately 60% of patients with relapsed or refractory (r/r) aggressive B cell lymphoma (B-NHL) do not achieve durable benefit from CAR-T cell therapy. To elucidate factors associated with CAR-T therapy resistance, we conducted high-dimensional analyses of pre- and post-CAR-T cell specimens. In patients with non-durable response, we identified a prognostically relevant lymphoma-associated myeloid-monocytic (LAMM) gene signature. In-depth profiling revealed a distinct CSF1R+CD14+CD68+ LAMM cell population in both human and murine B-NHL that inhibits CAR-T cell function and correlates with poor outcome. Cell-cell inference analysis uncovered that LAMM cells impair CAR-T cell function through a direct LAMM-T cell interaction via the PGE2-EP2/EP4 axis. In an autochthonous lymphoma mouse model, combined anti-CD19 CAR-T cell therapy with CSF1R blockade exhibited synergistic effects and improved survival. These findings provide strong rationale for combining anti-CD19 CAR-T cells with CSF1R inhibitors in treating r/r aggressive B-NHL patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immunotherapy, AdoptiveReceptors, Granulocyte-Macrophage Colony-Stimulating FactorLymphoma, B-CellReceptors, Chimeric AntigenMyeloid CellsAnimalsHumansMiceCell Line, TumorXenograft Model Antitumor AssaysDrug Resistance, NeoplasmReceptor, Macrophage Colony-Stimulating Factor

Stichwörter der Autor:innen

CAR-T cellCSF1Raggressive B-NHLlymphoma tumor microenvironmentmyeloid cells

Substanzen

Receptors, Granulocyte-Macrophage Colony-Stimulating FactorCSF1R protein, humanReceptors, Chimeric AntigenReceptor, Macrophage Colony-Stimulating Factor

Autor:innen und Institutionen

  • Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Molecular Medic…
  • Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Department of Translationa…
  • Division of Clinical Pharmacology, Department of Medicine IV, LMU University Hospital, Member of the German Center for Lung Research (DZL), LMU Munich, Munich, Germany.
  • Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany; University of Cologne, Institute for Biomedical Informatics, Faculty of Medicine and University Hospital Cologne, Cologne, Germany.
  • Institute of Pathology, University Hospital Cologne, Faculty of Medicine, University of Cologne, Cologne, Germany.
  • Stanford Center for Cancer Cell Therapy, Stanford Cancer Institute, Stanford University, Stanford, CA, USA; Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA; Parker Instit…

Förderung

  • Deutsche Forschungsgemeinschaft
  • Horizon 2020
  • Hector Stiftung
  • José Carreras Leukämie-Stiftung
  • Fritz-Bender-Stiftung
  • Bundesministerium für Bildung und Forschung
  • German Cancer Aid
  • Horizon 2020 Framework Programme

Zitieren

APA

Stahl, D., Gödel, P., Balke-Want, H., Gholamipoorfard, R., Segbers, P., Tetenborg, L., Koker, M., Dörr, J., Gregor, L., Bachurski, D., Rose, F., Simon, A. G., Good, Z., Jakob, J., Häupl, B., Nill, M., Flümann, R., Riet, T., Lange, D., …, & Ullrich, R. T. (2025). CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma. Cancer Cell, 43(8), 1476-1494.e10. https://doi.org/10.1016/j.ccell.2025.05.013

Vancouver

Stahl D, Gödel P, Balke-Want H, Gholamipoorfard R, Segbers P, Tetenborg L, et al. CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma. Cancer Cell. 2025;43(8):1476-1494.e10. doi:10.1016/j.ccell.2025.05.013

BibTeX
@article{Stahl2025,
  author = {Stahl, David and Gödel, Philipp and Balke-Want, Hyatt and Gholamipoorfard, Rahil and Segbers, Paul and Tetenborg, Luis and Koker, Mirjam and Dörr, Janina and Gregor, Lisa and Bachurski, Daniel and Rose, France and Simon, Adrian G and Good, Zinaida and Jakob, Josefine and Häupl, Björn and Nill, Marieke and Flümann, Ruth and Riet, Tobias and Lange, Dinah and Blakemore, Stuart J and Baurmann, Herrad and Voltin, Conrad-Amadeus and Potter, Nicole and Schlözer, Lilli and Freihammer, Max and Wagener-Ryczek, Svenja and Iuga, Andra-Iza and Heger, Jan-Michel and Ludwig, Hanna and Schleifenbaum, Julia K and Propp, Jessica and Bröckelmann, Paul J and Jachimowicz, Ron D and Knittel, Gero and Borchmann, Sven and Merkelbach-Bruse, Sabine and Pallasch, Christian and Peifer, Martin and Rybniker, Jan and Quaas, Alexander and Nitz, Mark and Brägelmann, Johannes and Müller, Werner and Persigehl, Thorsten and Bozek, Katarzyna and Theobald, Sebastian J and Büttner, Reinhard and Oellerich, Thomas and Hallek, Michael and Kobold, Sebastian and Chmielewski, Markus and Reinhardt, Hans Christian and Mackall, Crystal and Abedpour, Nima and Borchmann, Peter and Ullrich, Roland T},
  title = {CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma},
  journal = {Cancer Cell},
  year = {2025},
  volume = {43},
  number = {8},
  pages = {1476--1494.e10},
  doi = {10.1016/j.ccell.2025.05.013}
}
Kostenlos starten →